对肝胆癌的新点和新药
Stephen L Chan1, Angela Lamarca2, Chiun Hsu3
1State Key Laboratory of Translational Oncology, Department of Clinical Oncology, Sir YK Pao Centre for Cancer, Hong Kong Cancer Institute, Prince of Wales Hospital, The Chinese University of Hong Kong, Hong Kong, China; Department of Clinical Oncology, Sir YK Pao Centre for Cancer, Hong Kong Cancer Institute, Prince of Wales Hospital, The Chinese University of Hong Kong, Hong Kong, China.
肝胆癌的新疗法正在出现, 针对免疫系统和以前无法治疗的目标. 临床试验正在探索新的免疫疗法,细胞疗法和抗体-药物结合物用于肝脏和胆道癌症.
科学领域:
- 癌症学
- 免疫疗法
- 药物开发
背景情况:
- 肝胆癌 (HCC和BTC) 的治疗进展迅速.
- 常规疗法正在通过针对免疫系统和具有挑战性的分子点的新方法来补充.
研究的目的:
- 审查目前和新兴的肝胆癌治疗策略.
- 突出免疫疗法,细胞疗法和向药物开发的进展.
主要方法:
- 对肝胆癌治疗的当前研究和临床试验的回顾.
- 专注于新型免疫检查点抑制剂,细胞疗法 (CAR-T,TIL),双特异性抗体和抗体与药物联合体.
- 探索新目标和传统的无毒目标.
主要成果:
- 药物开发的两个主要方向:免疫系统调节和针对新/无法抗药的目标.
- 新兴疗法包括新型免疫检查点抗体,细胞因子,CAR-T细胞,TIL细胞,双特异性T细胞参与剂和抗体-药物结合物.
- 早期临床研究显示,HCC和BTC的细胞疗法具有前景;针对特定的BTC亚型开发了抗体-药物联合体.
结论:
- 治疗的进步正在重塑肝胆癌的治疗模式,包括罕见的亚型,如类肝癌和结合性肝癌 - 胆管癌.
- 这些新型治疗方法,包括免疫检查点抑制剂,对罕见的肝癌亚型具有潜力,因此需要将其纳入临床试验.
更多相关视频
06:38An Oncogenic Hepatocyte-Induced Orthotopic Mouse Model of Hepatocellular Cancer Arising in the Setting of Hepatic Inflammation and Fibrosis
Published on: September 12, 2019
09:11Y-90 Radioembolization and PD-1 Inhibitor as Neoadjuvant Treatment in Hepatocellular Carcinoma
Published on: May 24, 2024
相关概念视频
Targeted Cancer Therapies
There are several types of targeted therapies against...
Targets for Drug Action: Overview
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
Treatment Resistant Cancers
Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
